Product Focus: Screening Robotics and Automation

Q2 Chemistry

Journal of Biomolecular Screening Pub Date : 2008-07-01 DOI:10.1177/10870571080130061201

引用次数: 0

Abstract

BioTek Instruments has announced the Synergy 4 multidetection microplate reader, which combines a fluorescence filter-based detection system and a monochromator-based detection system in 1 unit. The filter-based system can be used when high sensitivity or fast read speeds are a requirement. The monochromator system is available when spectral scanning is needed. This modular reader can be ordered fully loaded with all measurement modes or customized to fit budgetary requirements with the option to add other detection technologies at a later date. Available options include filterbased and monochromator-based fluorescence intensity, time-resolved fluorescence, fluorescence polarization, UV-visible absorbance, flash and glow luminescence, and a dual-reagent

查看原文本刊更多论文

产品重点:筛选机器人及自动化

BioTek Instruments宣布了Synergy 4多检测微孔板阅读器，该阅读器将基于荧光滤光片的检测系统和基于单色仪的检测系统结合在一起。当需要高灵敏度或快速读取速度时，可使用基于滤波器的系统。当需要进行光谱扫描时，可以使用单色仪系统。这种模块化阅读器可以订购满载所有测量模式或定制，以适应预算要求，并可在以后添加其他检测技术。可用的选项包括基于滤光片和基于单色器的荧光强度，时间分辨荧光，荧光偏振，紫外可见吸光度，闪光和发光，以及双试剂

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Biomolecular Screening 生物-分析化学

CiteScore

2.41

自引率

0.00%

发文量

审稿时长

4-8 weeks

期刊介绍： Advancing the Science of Drug Discovery: SLAS Discovery reports how scientists develop and utilize novel technologies and/or approaches to provide and characterize chemical and biological tools to understand and treat human disease. SLAS Discovery is a peer-reviewed journal that publishes scientific reports that enable and improve target validation, evaluate current drug discovery technologies, provide novel research tools, and incorporate research approaches that enhance depth of knowledge and drug discovery success. SLAS Discovery emphasizes scientific and technical advances in target identification/validation (including chemical probes, RNA silencing, gene editing technologies); biomarker discovery; assay development; virtual, medium- or high-throughput screening (biochemical and biological, biophysical, phenotypic, toxicological, ADME); lead generation/optimization; chemical biology; and informatics (data analysis, image analysis, statistics, bio- and chemo-informatics). Review articles on target biology, new paradigms in drug discovery and advances in drug discovery technologies. SLAS Discovery is of particular interest to those involved in analytical chemistry, applied microbiology, automation, biochemistry, bioengineering, biomedical optics, biotechnology, bioinformatics, cell biology, DNA science and technology, genetics, information technology, medicinal chemistry, molecular biology, natural products chemistry, organic chemistry, pharmacology, spectroscopy, and toxicology.